Journey Medical Corporation Common Stock

DERM US48115J1097

💰
Capitalization
Small-cap

Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's portfolio includes eight branded and three authorized generic prescription drugs for dermatological conditions that are marketed in the United States. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.

Annual Insiders Turnover, USD 2

1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);

Insider Activity
📊
Transactions
23
🙍
Insiders
6
Person Price Shares Total Published Completed
Alloush Ramsey
COO
6.84
USD
2,857
Sold
19,542
USD
02/05/2025 02/05/2025
Maraoui Claude
CEO
6.84
USD
4,834
Sold
33,065
USD
02/05/2025 02/05/2025
Maraoui Claude
CEO
6.84
USD
4,834
Sold
33,065
USD
02/05/2025 02/05/2025
Alloush Ramsey
COO
6.84
USD
2,857
Sold
19,542
USD
02/05/2025 02/05/2025
Benesch Joseph
CFO
6.84
USD
2,409
Sold
16,478
USD
02/05/2025 02/05/2025
Benesch Joseph
CFO
6.84
USD
2,409
Sold
16,478
USD
02/05/2025 02/05/2025
Maraoui Claude
CEO
5.01
USD
49,271
Sold
246,848
USD
11/03/2025 11/03/2025
Maraoui Claude
CEO
5.01
USD
14,905
Sold
74,674
USD
06/03/2025 07/03/2025
Maraoui Claude
CEO
5.04
USD
25,551
Sold
128,777
USD
06/03/2025 06/03/2025
Maraoui Claude
CEO
5.13
USD
18,147
Sold
93,094
USD
03/03/2025 05/03/2025

Integrated EOD Stock Data and Insider Transactions Chart

Sign in or subscribe to include Journey Medical Corporation Common Stock to your watchlist and receive automatic alerts for upcoming transactions.

The visibility of insider buy and sell transactions on this chart should not be the sole factor in your decision to buy or sell a particular stock. Always consider the following dynamic reports for a broader understanding of stock market activities:

 

Last 52W Low 52W High All-Time Low All-Time High β
Company Insiders
Person / Entity Transactions Turnover, USD Average, USD First Last
Maraoui Claude 9 911,979.59 101,331.07 22/03/2024 02/05/2025
Benesch Joseph 6 122,126.25 20,354.38 22/02/2024 02/05/2025
Smith Justin Adam 1 104,100.00 104,100.00 22/03/2024 22/03/2024
Rosenwald Lindsay A Md 2 98,400.00 49,200.00 22/03/2024 25/03/2024
Alloush Ramsey 2 39,083.76 19,541.88 02/05/2025 02/05/2025
Paley Jeffrey 3 17,880.30 5,960.10 07/11/2023 28/11/2023

Insiders marked in yellow represent long-term insiders. These are individuals who have engaged in transactions for over 3 years and have conducted at least 10 transactions or reached a cumulative turnover of $1M USD. When examining transaction clusters, we prioritize those conducted by long-term insiders for analysis.

Stock Advanced Metrics
Delta Correlation subscribe 🔒
Upper Bound of Standardized Transaction Amount (ubsta), USD 4 subscribe 🔒

4 represents the maximum expected transaction amount for a company's insiders, calculated based on historical data. It provides insight into the typical range of insider transaction amounts and helps in identifying unusually large transactions.

5 a proprietary metric reflecting the consistency of insider trading behavior within a company. A higher discipline index suggests more regular and predictable insider transactions.